*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Treprostinil is a synthetic prostacyclin analogue used primarily for treating pulmonary arterial hypertension. Its industrial synthesis involves complex organic reactions to ensure high purity. The chemical formula is <strong>C<sub>23</sub>H<sub>40</sub>O<sub>5</sub></strong> and the CAS number is <strong>169195-83-7</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Pulmonary Medicine:</strong> Management of PAH to reduce vascular resistance.</li>
<li><strong>Cardiovascular Therapy:</strong> Intravenous or subcutaneous infusion protocols.</li>
<li><strong>Research & Development:</strong> Clinical trials for novel vasodilator formulations.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated in patients with severe liver impairment. Requires storage below 25°C in dry conditions to maintain stability. Handling must adhere to pharmaceutical safety standards regarding potent vasoactive agents.</p>